This research addresses an important and timely topic in cancer treatment, as the authors present a novel computational tool, 'retriever,' which has the potential to revolutionize personalized cancer ...

Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's ...

Pfizer's late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS ...

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...

From research to 'route of administration' to recovery, when it comes to illicit substances, a little planning goes a long ...

Here’s a chart of drugs that can interact with Ozempic ... insulin dose if you have low blood sugar while using Ozempic in combination with your insulin medication. Or your doctor may suggest ...

Researchers found that a combination therapy of two drugs disrupts this pathway, helping to suppress the creation of cancer cells and tumor growth. This combo of medications includes a statin ...

Results from a small retrospective analysis of patients with upper tract urothelial carcinoma lesions were shared at the 2025 ASCO Genitourinary Cancers Symposium.

You may receive a combination of therapies or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted therapies ...

Buy DRUG near 34.19 target 54.82 stop loss @ 34.09 Details The technical summary data tells us to buy DRUG near 34.19 with an upside target of 54.82. This data also tells us to set a stop loss @ 34.09 ...